William Blair Has Negative View of Penumbra FY2025 Earnings

Penumbra, Inc. (NYSE:PEN - Free Report) - Analysts at William Blair dropped their FY2025 EPS estimates for shares of Penumbra in a report issued on Wednesday, April 2nd. William Blair analyst M. Andrew now anticipates that the company will post earnings of $3.67 per share for the year, down from their previous estimate of $3.91. The consensus estimate for Penumbra's current full-year earnings is $3.67 per share.

Penumbra (NYSE:PEN - Get Free Report) last released its earnings results on Tuesday, February 18th. The company reported $0.97 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.88 by $0.09. Penumbra had a return on equity of 9.74% and a net margin of 1.17%. The business had revenue of $315.52 million for the quarter, compared to the consensus estimate of $311.63 million.

PEN has been the subject of several other reports. Morgan Stanley raised their target price on shares of Penumbra from $240.00 to $260.00 and gave the company an "equal weight" rating in a research note on Wednesday, February 19th. JPMorgan Chase & Co. increased their price target on shares of Penumbra from $230.00 to $285.00 and gave the company an "overweight" rating in a research note on Wednesday, February 19th. Oppenheimer initiated coverage on shares of Penumbra in a research note on Tuesday, December 17th. They set an "outperform" rating and a $275.00 price objective on the stock. Piper Sandler reiterated an "overweight" rating and issued a $330.00 target price (up from $250.00) on shares of Penumbra in a research note on Wednesday, February 19th. Finally, Royal Bank of Canada lifted their price target on Penumbra from $285.00 to $313.00 and gave the stock an "outperform" rating in a report on Wednesday, February 19th. Four equities research analysts have rated the stock with a hold rating, thirteen have assigned a buy rating and one has assigned a strong buy rating to the stock. According to data from MarketBeat.com, Penumbra has a consensus rating of "Moderate Buy" and an average target price of $293.80.

Penumbra Stock Up 1.4 %

Shares of NYSE:PEN traded up $3.87 during trading on Monday, hitting $272.44. 388,806 shares of the company were exchanged, compared to its average volume of 411,290. Penumbra has a fifty-two week low of $148.00 and a fifty-two week high of $310.00. The stock has a market cap of $10.49 billion, a price-to-earnings ratio of 801.28, a P/E/G ratio of 2.83 and a beta of 0.56. The company has a current ratio of 6.01, a quick ratio of 3.25 and a debt-to-equity ratio of 0.02. The firm has a fifty day moving average price of $274.33 and a two-hundred day moving average price of $248.80.

Insider Buying and Selling at Penumbra

In other news, CAO Lambert Shiu sold 501 shares of the business's stock in a transaction dated Tuesday, March 4th. The shares were sold at an average price of $282.88, for a total value of $141,722.88. Following the completion of the sale, the chief accounting officer now owns 32,969 shares of the company's stock, valued at approximately $9,326,270.72. The trade was a 1.50 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, EVP Johanna Roberts sold 600 shares of the company's stock in a transaction dated Monday, March 3rd. The shares were sold at an average price of $287.43, for a total transaction of $172,458.00. Following the completion of the transaction, the executive vice president now owns 66,539 shares in the company, valued at $19,125,304.77. This trade represents a 0.89 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 111,236 shares of company stock valued at $31,222,390 in the last ninety days. 5.00% of the stock is currently owned by corporate insiders.

Institutional Inflows and Outflows

Several hedge funds have recently made changes to their positions in PEN. Merit Financial Group LLC acquired a new stake in Penumbra during the first quarter worth approximately $207,000. Milestone Asset Management LLC bought a new stake in shares of Penumbra during the 1st quarter valued at $209,000. GAMMA Investing LLC grew its holdings in shares of Penumbra by 42,409.9% during the 1st quarter. GAMMA Investing LLC now owns 189,594 shares of the company's stock worth $50,699,000 after purchasing an additional 189,148 shares in the last quarter. Versant Capital Management Inc increased its position in shares of Penumbra by 893.5% in the first quarter. Versant Capital Management Inc now owns 308 shares of the company's stock worth $82,000 after purchasing an additional 277 shares during the period. Finally, Wealth Enhancement Advisory Services LLC increased its position in shares of Penumbra by 74.7% in the fourth quarter. Wealth Enhancement Advisory Services LLC now owns 3,115 shares of the company's stock worth $740,000 after purchasing an additional 1,332 shares during the period. 88.88% of the stock is owned by institutional investors.

About Penumbra

Penumbra, Inc, together with its subsidiaries, designs, develops, manufactures, and markets medical devices in the United States and internationally. The company offers peripheral products, including the Indigo System for power aspiration of thrombus in the body; Lightning Flash, a mechanical thrombectomy system; Lightning Bolt 7, an arterial thrombectomy system; and CAT RX.